Rice Hall James & Associates’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.7M Buy
477,416
+9,530
+2% +$485K 1.37% 23
2025
Q4
$23.3M Sell
467,886
-8,195
-2% -$398K 1.28% 24
2025
Q3
$22.8M Sell
476,081
-48,566
-9% -$1.96M 1.24% 22
2025
Q2
$16.5M Buy
524,647
+8,758
+2% +$281K 0.89% 32
2025
Q1
$16.9M Sell
515,889
-12,456
-2% -$441K 0.99% 29
2024
Q4
$19.1M Sell
528,345
-12,443
-2% -$438K 1.05% 28
2024
Q3
$16.9M Buy
540,788
+38,202
+8% +$1.19M 0.91% 27
2024
Q2
$13.4M Sell
502,586
-14,187
-3% -$411K 0.81% 33
2024
Q1
$17.6M Sell
516,773
-13,179
-2% -$392K 1.01% 24
2023
Q4
$15.3M Sell
529,952
-14,516
-3% -$385K 0.89% 34
2023
Q3
$15M Sell
544,468
-10,325
-2% -$314K 0.95% 30
2023
Q2
$16.7M Buy
554,793
+3,508
+0.6% +$123K 0.95% 32
2023
Q1
$20M Sell
551,285
-68,042
-11% -$2.62M 1.13% 24
2022
Q4
$22.1M Sell
619,327
-59,984
-9% -$2.08M 1.27% 17
2022
Q3
$23M Sell
679,311
-154,641
-19% -$5.03M 1.33% 19
2022
Q2
$24.1M Sell
833,952
-20,997
-2% -$601K 1.17% 24
2022
Q1
$27.6M Sell
854,949
-1,906
-0.2% -$58.4K 1.1% 26
2021
Q4
$25M Sell
856,855
-58,026
-6% -$1.76M 0.89% 35
2021
Q3
$24.4M Sell
914,881
-7,978
-0.9% -$214K 0.9% 36
2021
Q2
$28.4M Sell
922,859
-112,230
-11% -$3.44M 1.01% 30
2021
Q1
$27.1M Sell
1,035,089
-2,289
-0.2% -$64K 0.88% 36
2020
Q4
$26.1M Buy
1,037,378
+27,764
+3% +$598K 0.92% 37
2020
Q3
$21M Buy
1,009,614
+84,128
+9% +$1.91M 0.85% 36
2020
Q2
$22M Sell
925,486
-22,069
-2% -$488K 0.94% 32
2020
Q1
$17M Sell
947,555
-14,418
-1% -$303K 0.95% 31
2019
Q4
$22.8M Buy
961,973
+24,900
+3% +$605K 0.77% 36
2019
Q3
$25.8M Sell
937,073
-414,213
-31% -$12.3M 0.92% 30
2019
Q2
$44.7M Buy
1,351,286
+350,905
+35% +$12M 1.49% 14
2019
Q1
$35.1M Buy
1,000,381
+86,645
+9% +$3.22M 1.13% 24
2018
Q4
$30.4M Buy
913,736
+274,844
+43% +$11.8M 1.11% 24
2018
Q3
$32.2M Sell
638,892
-163,769
-20% -$8.09M 1.15% 15
2018
Q2
$48M Sell
802,661
-499,067
-38% -$25.9M 1.75% 7
2018
Q1
$59.6M Sell
1,301,728
-20,886
-2% -$872K 2.33% 3
2017
Q4
$52.7M Buy
1,322,614
+98,297
+8% +$3.88M 2.07% 3
2017
Q3
$49M Sell
1,224,317
-137,056
-10% -$5.93M 2.17% 2
2017
Q2
$58.7M Buy
1,361,373
+267,971
+25% +$9.54M 2.55% 1
2017
Q1
$34.2M Buy
1,093,402
+11,662
+1% +$313K 1.67% 2
2016
Q4
$27.3M Buy
1,081,740
+477,498
+79% +$10.7M 1.38% 5
2016
Q3
$14.9M Buy
604,242
+60,636
+11% +$1.37M 0.78% 59
2016
Q2
$11.1M Buy
543,606
+7,161
+1% +$127K 0.64% 69
2016
Q1
$8.18M Buy
536,445
+59,377
+12% +$775K 0.47% 81
2015
Q4
$6.41M Buy
477,068
+272,181
+133% +$4.21M 0.37% 84
2015
Q3
$2.88M Buy
204,887
+92,698
+83% +$1.72M 0.19% 122
2015
Q2
$1.91M Buy
+112,189
New +$1.6M 0.11% 201

Other funds holding SUPN